Table 13.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Heart-Lung Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 1 100.0% 126 100.0%
Induction Drugs        
Atgam/NRATG/NRATS     14 11.1%
OKT3     5 4.0%
Thymoglobulin     11 8.7%
Zenapax     21 16.7%
Simulect     20 15.9%
Campath     10 7.9%
Rituximab        
No Induction Drug Reported 1 100.0% 47 37.3%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.